Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1953 Jan;78(1):44–58.

CHEMICAL AGENTS IN NEOPLASTIC DISEASES—An Evaluation of Chemotherapeutic Substances for Clinical Management

Howard R Bierman
PMCID: PMC1521576  PMID: 13009518

Abstract

The rapid appearance of many new chemical substances which possess some antineoplastic effects has created a complex problem for the practicing physician. These agents which have shown promise in man and lower animals are grouped according to their modes of action. Each substance is discussed thoroughly with regard to its structure, activity, and influence upon the neoplasms of man. Key references are cited, and the practical value of each chemical agent is defined. The proper methods of administration of the compounds recommended for use are carefully described. In addition a section on agents whose therapeutic value has been disproven is also included.

Full text

PDF
44

Images in this article

45Figure 1.
on p.45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMISTEAD G. C., Jr, BURCHENAL J. H. Preliminary studies on the clinical toxicity of 5-amino-7-hydroxy-1-v-triazolo[d]-pyrimidine. Cancer. 1949 Nov;2(6):1087–illust. doi: 10.1002/1097-0142(194911)2:6<1087::aid-cncr2820020614>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  2. BIERMAN H. R., BYRON R. L., Jr, KELLEY K. H., GRADY A. Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst. 1951 Aug;12(1):107–131. [PubMed] [Google Scholar]
  3. BIERMAN H. R., COHEN P., McCLELLAND J. N., SHIMKIN M. B. The effect of transfusions and antibiotics upon the duration of life in children with lymphogenous leucemia. J Pediatr. 1950 Oct;37(4):455–462. doi: 10.1016/s0022-3476(50)80254-8. [DOI] [PubMed] [Google Scholar]
  4. BIERMAN H. R., KELLY K. H., DOD K. S., BYRON R. L., Jr Studies on the blood supply of tumors in man. I. Fluorescence of cutaneous lesions. J Natl Cancer Inst. 1951 Apr;11(5):877–889. [PubMed] [Google Scholar]
  5. BIERMAN H. R., MILLER E. R., BYRON R. L., DOD K. S., KELLY K. H., BLACK D. H. Intra-arterial catheterization of viscera in man. Am J Roentgenol Radium Ther. 1951 Oct;66(4):555–568. [PubMed] [Google Scholar]
  6. BIERMAN H. R., SHIMKIN M. B. Methyl-bis (beta-chloroethyl)amine in large doses in the treatment of neoplastic diseases. Calif Med. 1949 Aug;71(2):117–125. [PMC free article] [PubMed] [Google Scholar]
  7. BIERMAN H. R., SOKOLOW M. Cardiovascular effects produced by stilbamidine in patients with multiple myeloma. J Natl Cancer Inst. 1949 Oct;10(2):279-89, incl 3 pl. [PubMed] [Google Scholar]
  8. BISHOP P. M. F., FOLLEY S. J. Absorption of hormone implants in man. Lancet. 1951 Aug 11;2(6676):229–232. doi: 10.1016/s0140-6736(51)93237-0. [DOI] [PubMed] [Google Scholar]
  9. BURCHENAL J. H., WEBBER L. F., MEIGS G. M., BIEDLER J. L. A comparison of the effects of 4-amino-N10-methyl-pteroylglutamic acid and 2,6-diaminopurine upon sensitive and resistant sublines of a strain of mouse leukemia. Blood. 1951 Apr;6(4):337–343. [PubMed] [Google Scholar]
  10. Bierman H. R. MEDICAL PROGRESS: NEWER METHODS OF TREATMENT OF LEUKEMIAS AND LYMPHOMAS. Calif Med. 1948 Oct;69(4):285–289. [PMC free article] [PubMed] [Google Scholar]
  11. CAMPBELI J. H., CUMMINS S. D. Metastases, simulating mammary cancer, in prostatic carcinoma under estrogenic therapy. Cancer. 1951 Mar;4(2):303–311. doi: 10.1002/1097-0142(195103)4:2<303::aid-cncr2820040215>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  12. GARLAND L. H., BAKER M., PICARD W. H., Jr, SISSON M. A. Roentgen and steroid hormone therapy in mammary cancer metastatic to bone. J Am Med Assoc. 1950 Nov 18;144(12):997–1004. doi: 10.1001/jama.1950.62920120003008. [DOI] [PubMed] [Google Scholar]
  13. GELLHORN A., COLLINS V. P. A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin's disease. Ann Intern Med. 1951 Dec;35(6):1250–1259. doi: 10.7326/0003-4819-35-6-1250. [DOI] [PubMed] [Google Scholar]
  14. GOLDIN A., GREENSPAN E. M., SCHOENBACH E. B. Studies on the mechanism of action of chemotherapeutic agents in cancer. VI. Synergistic (additive) action of drugs on a transplantable leukemia in mice. Cancer. 1952 Jan;5(1):153–160. doi: 10.1002/1097-0142(195201)5:1<153::aid-cncr2820050121>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  15. GREENSPAN E. M., LEITER J., SHEAR M. J. Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors. J Natl Cancer Inst. 1950 Jun;10(6):1295–1333. [PubMed] [Google Scholar]
  16. GRIBOFF S. I. The rationale and clinical use of steroid hormones in cancer. AMA Arch Intern Med. 1952 May;89(5):812–concl. doi: 10.1001/archinte.1952.00240050126010. [DOI] [PubMed] [Google Scholar]
  17. HADDOW A., TIMMIS G. M. Bifunctional sulphonic acid esters with radiomimetic activity. Acta Unio Int Contra Cancrum. 1951;7(3):469–471. [PubMed] [Google Scholar]
  18. HARRISON J. H., POUTASSE E. F. Management of carcinoma of the prostate; study of hormonal and surgical therapy in 100 patients. Am J Med. 1951 Jul;11(1):55–66. doi: 10.1016/0002-9343(51)90008-3. [DOI] [PubMed] [Google Scholar]
  19. HENCH P. S., KENDALL E. C., SLOCUMB C. H., POLLEY H. F. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med (Chic) 1950 Apr;85(4):545–666. doi: 10.1001/archinte.1950.00230100002001. [DOI] [PubMed] [Google Scholar]
  20. HIGGINS G. K., PACK G. T. Virus therapy in the treatment of tumors. Bull Hosp Joint Dis. 1951 Oct;12(2):379–382. [PubMed] [Google Scholar]
  21. HOMBURGER F., KASDON S. C., FISHMAN W. H. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast. Proc Soc Exp Biol Med. 1950 May;74(1):162–164. doi: 10.3181/00379727-74-17840. [DOI] [PubMed] [Google Scholar]
  22. Hauschka T. S., Goodwin M. B. Trypanosoma cruzi Endotoxin (KR) in the Treatment of Malignant Mouse Tumors. Science. 1948 Jun 4;107(2788):600–602. doi: 10.1126/science.107.2788.600. [DOI] [PubMed] [Google Scholar]
  23. INGLE D. J. The biologic properties of cortisone: a review. J Clin Endocrinol Metab. 1950 Oct;10(10):1312–1354. doi: 10.1210/jcem-10-10-1312. [DOI] [PubMed] [Google Scholar]
  24. ISAACS R., TRIMMER R. W. Blood cell changes in leukemia during aminopterin therapy. Ann Intern Med. 1951 Jul;35(1):236–239. doi: 10.7326/0003-4819-35-1-236. [DOI] [PubMed] [Google Scholar]
  25. JUKES T. H., FRANKLIN A. L., STOKSTAD E. L. R. Pteroylglutamic acid antagonists. Ann N Y Acad Sci. 1950 Jul 7;52(8):1336–1341. doi: 10.1111/j.1749-6632.1950.tb54033.x. [DOI] [PubMed] [Google Scholar]
  26. KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
  27. KARNOFSKY D. A., GRAEF I., SMITH H. W. Studies on the mechanism of action of the nitrogen and sulfur mustards in vivo. Am J Pathol. 1948 Mar;24(2):275–291. [PMC free article] [PubMed] [Google Scholar]
  28. KARNOFSKY D. A. Nitrogen mustards in the treatment of neoplastic disease. Adv Intern Med. 1950;4:1–75. [PubMed] [Google Scholar]
  29. KASDON S. C., FISHMAN W. H., DART R. M., BONNER C. D., HOMBURGER F. Methylandrostenediol in palliative treatment of breast cancer. J Am Med Assoc. 1952 Apr 5;148(14):1212–1216. doi: 10.1001/jama.1952.02930140044014. [DOI] [PubMed] [Google Scholar]
  30. KASS E. H., FINLAND M. The role of adrenal steroids in infection and immunity. N Engl J Med. 1951 Mar 29;244(13):464–470. doi: 10.1056/NEJM195103292441302. [DOI] [PubMed] [Google Scholar]
  31. KELLY K. H., BIERMAN H. R., SHIMKIN M. B. Negative effects of oral monobenzyl ether of hydroquinone in malignant melanoma in man. Proc Soc Exp Biol Med. 1952 Apr;79(4):589–590. doi: 10.3181/00379727-79-19456. [DOI] [PubMed] [Google Scholar]
  32. KLOPP C. T., ALFORD T. C., BATEMAN J., BERRY G. N., WINSHIP T. Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg. 1950 Oct;132(4):811–832. doi: 10.1097/00000658-195010000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kidder G. W., Dewey V. C., Parks R. E., Jr, Woodside G. L. Purine Metabolism in Tetrahymena and Its Relation to Malignant Cells in Mice. Science. 1949 May 20;109(2838):511–514. doi: 10.1126/science.109.2838.511. [DOI] [PubMed] [Google Scholar]
  34. LEITER J., DOWNING V., HARTWELL J. L., SHEAR M. J. Damage induced in sarcoma 37 with podophyllin, podophyllotoxin alpha-peltatin, beta-peltatin, and quercetin. J Natl Cancer Inst. 1950 Jun;10(6):1273–1293. [PubMed] [Google Scholar]
  35. LOWENHAUPT E., BROWN R. Carcinoma of the thymus of granulomatous type; a clinical and pathological study. Cancer. 1951 Nov;4(6):1193–1209. doi: 10.1002/1097-0142(195111)4:6<1193::aid-cncr2820040606>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  36. MATTHEWS W. B. A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases. Lancet. 1950 May 13;1(6611):896–899. doi: 10.1016/s0140-6736(50)90732-x. [DOI] [PubMed] [Google Scholar]
  37. Malisoff W. M. The Action of the Endotoxin of Trypanosoma cruzi (KR) on Malignant Mouse Tumors. Science. 1947 Dec 12;106(2763):591–594. doi: 10.1126/science.106.2763.591-a. [DOI] [PubMed] [Google Scholar]
  38. NATHANSON I. T., KELLEY R. M. Hormonal treatment of cancer. N Engl J Med. 1952 Jan 31;246(5):180–concl. doi: 10.1056/NEJM195201312460505. [DOI] [PubMed] [Google Scholar]
  39. NESBIT R. M., BAUM W. C. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. J Am Med Assoc. 1950 Aug 12;143(15):1317–1320. doi: 10.1001/jama.1950.02910500019005. [DOI] [PubMed] [Google Scholar]
  40. PACK G. T. Note on the experimental use of rabies vaccine for melanomatosis. AMA Arch Derm Syphilol. 1950 Nov;62(5):694–695. doi: 10.1001/archderm.1950.01530180083015. [DOI] [PubMed] [Google Scholar]
  41. PATERSON E., BOLAND J. Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial. Br J Cancer. 1951 Mar;5(1):28–37. doi: 10.1038/bjc.1951.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. PERRAULT M. Etat actuel du H-365, para-oxy-propiophénone, frénateur hypophysaire de synthèse. Presse Med. 1950 Sep 27;58(59):1010–1013. [PubMed] [Google Scholar]
  43. PHILIPS F. S. Recent contributions to the pharmacology of bis(2-haloethyl) amines and sulfides. J Pharmacol Exp Ther. 1950 Aug;99(42):281–323. [PubMed] [Google Scholar]
  44. PHILIPS F. S., THIERSCH J. B. The nitrogen mustard-like actions of 2,4,6-tris (ethylenimino)-s-triazine and other bis(ethylenimines). J Pharmacol Exp Ther. 1950 Dec;100(41):398–407. [PubMed] [Google Scholar]
  45. RENOLD A. E., FORSHAM P. H., MAISTERRENA J., THORN G. W. Intravenously administered ACTH: a preliminary report. N Engl J Med. 1951 May 24;244(21):796–798. doi: 10.1056/NEJM195105242442104. [DOI] [PubMed] [Google Scholar]
  46. ROSE F. L., HENDRY J. A., WALPOLE A. L. New cytotoxic agents with tumour-inhibitory activity. Nature. 1950 Jun 24;165(4208):993–996. doi: 10.1038/165993a0. [DOI] [PubMed] [Google Scholar]
  47. RUNDLES R. W., BARTON W. B. Triethylene melamine in the treatment of neoplastic disease. Blood. 1952 May;7(5):483–507. [PubMed] [Google Scholar]
  48. RUNDLES R. W., REEVES R. J. Multiple myeloma. II. Variability of roentgen appearance and effect of urethane therapy on skeletal disease. Am J Roentgenol Radium Ther. 1950 Nov;64(5):799–809. [PubMed] [Google Scholar]
  49. SEGALOFF A., GORDON D., HORWITT B. N., SCHLOSSER J. V., MURISON P. J. Hormonal therapy in cancer of the breast. II. Effect of methylandrostenediol on clinical course and hormonal excretion. Cancer. 1952 Mar;5(2):271–274. doi: 10.1002/1097-0142(195203)5:2<271::aid-cncr2820050212>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  50. SELIGMAN A. M., RUTENBERG A. M., PERSKY L., FRIEDMAN O. M. Effect of 2-chloro-2'-hydroxydiethyl sulfide (hemisulfur mustard) on carcinomatosis with ascites. Cancer. 1952 Mar;5(2):354–363. doi: 10.1002/1097-0142(195203)5:2<354::aid-cncr2820050225>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  51. SHIMKIN M. B., BIERMAN H. R., KELLY K. H., LOWENHAUPT E., FURST A. Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases. Calif Med. 1951 Jul;75(1):26–34. [PMC free article] [PubMed] [Google Scholar]
  52. SILVERBERG J. H., DAMESHEK W. Use of triethylene melamine in treatment of leukemia and leukosarcoma. J Am Med Assoc. 1952 Mar 22;148(12):1015–1021. doi: 10.1001/jama.1952.02930120037009. [DOI] [PubMed] [Google Scholar]
  53. SMITH P. G., RUSH T. W., EVANS A. T. Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma. J Urol. 1951 May;65(5):886–889. doi: 10.1016/S0022-5347(17)68567-7. [DOI] [PubMed] [Google Scholar]
  54. SNELL E. E., CRAVENS W. W. Reversal of aminopterin inhibition in the chick embryo with desoxyribosides. Proc Soc Exp Biol Med. 1950 May;74(1):87–91. doi: 10.3181/00379727-74-17818. [DOI] [PubMed] [Google Scholar]
  55. SPRAGUE R. G., POWER M. H. Observations on the physiologic effects of cortisone and ACTH in man. Arch Intern Med (Chic) 1950 Feb;85(2):199–258. doi: 10.1001/archinte.1950.00230080003001. [DOI] [PubMed] [Google Scholar]
  56. STRAUS B., JACOBSON A. S., BERSON S. A., BERNSTEIN T. C., FADEM R. S., YALOW R. S. The effect of cortisone in Hodgkin's disease. Am J Med. 1952 Feb;12(2):170–189. doi: 10.1016/0002-9343(52)90210-6. [DOI] [PubMed] [Google Scholar]
  57. SWAN M. M., ZELMAN S. Myelokentric acid in the treatment of acute lymphoblastic leukemia. Ann Intern Med. 1950 Aug;33(2):438–442. doi: 10.7326/0003-4819-33-2-438. [DOI] [PubMed] [Google Scholar]
  58. Sullivan B. J., Wechsler H. I. The Cytological Effects of Podophyllin. Science. 1947 Apr 25;105(2730):433–433. doi: 10.1126/science.105.2730.433. [DOI] [PubMed] [Google Scholar]
  59. THORN G. W., FORSHAM P. H., FRAWLEY T. F., HILL S. R., Jr, ROCHE M., STAEHELIN D., WILSON D. L. The clinical usefulness of ACTH and cortisone. N Engl J Med. 1950 May 18;242(20):783–793. doi: 10.1056/NEJM195005182422005. [DOI] [PubMed] [Google Scholar]
  60. THORN G. W., FORSHAM P. H., FRAWLEY T. F., HILL S. R., Jr, ROCHE M., STAEHELIN D., WILSON D. L. The clinical usefulness of ACTH and cortisone. N Engl J Med. 1950 Jun 1;242(22):865–872. doi: 10.1056/NEJM195006012422205. [DOI] [PubMed] [Google Scholar]
  61. THORN G. W., RENOLD A. E., WILSON D. L., FRAWLEY T. F., JENKINS D., GARCIA-REYES J., FORSHAM P. H. Clinical studies on the activity of orally administered cortisone. N Engl J Med. 1951 Oct 11;245(15):549–555. doi: 10.1056/NEJM195110112451501. [DOI] [PubMed] [Google Scholar]
  62. WINTROBE M. M., CARTWRIGHT G. E., PALMER J. G., KUHNS W. J., SAMUELS L. T. Effect of corticotrophin and cortisone on the blood in various disorders in man. AMA Arch Intern Med. 1951 Sep;88(3):310–336. doi: 10.1001/archinte.1951.03810090041004. [DOI] [PubMed] [Google Scholar]
  63. WRIGHT J. C., PRIGOT A., WRIGHT L. T., ARONS I. Further observations on the use of triethylene melamine in neoplastic diseases. AMA Arch Intern Med. 1952 Mar;89(3):387–404. doi: 10.1001/archinte.1952.00240030036005. [DOI] [PubMed] [Google Scholar]
  64. WRIGHT L. T., WRIGHT J. C., PRIGOT A., WEINTRAUB S. Remissions caused by tri-ethylene melamine in certain neoplastic diseases. A preliminary report. J Natl Med Assoc. 1950 Nov;42(6):343–351. [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES